Evaluation of the Effect of Botulinum Toxin Type-A Injection Prior to Surgical Correction of Complete Unilateral Cleft Lip Repair by Modified Millard Cheiloplasty

Esthetic Outcome of Injection of Botulinum Toxin Type-A in Cleft Lip Repair Clinical Trial

Official title:

Evaluation of the Effect of Botulinum Toxin Type-A Injection Prior to Surgical Correction of Complete Unilateral Cleftlip Repair by Modified Millard Cheiloplasty

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03047499
• Other study ID #: CEBC-CU-2017-02-04
• Status: Recruiting
• Phase: N/A
• First received: February 7, 2017
• Last updated: February 8, 2017
• Start date: February 15, 2017
• Est. completion date: November 15, 2017

Study information

• Verified date: February 2017
• Source: Cairo University
• Contact: Mostafa Ayman Khairy
• Phone: 00201001155527
• Email: mostafakhairy100[@]hotmail.com
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Evaluation of the effect of botulinum toxin type-A injection prior to surgical correction of complete unilateral cleftlip repair by modified millard cheiloplasty

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 2
• Est. completion date: November 15, 2017
• Est. primary completion date: October 15, 2017
• Gender: All
• Age group: 3 Months to 6 Months

Eligibility

Inclusion Criteria:

• Primary cleft lip

Exclusion Criteria:

• Cleft palate

Related Conditions & MeSH terms

• Cleft Lip
• Esthetic Outcome of Injection of Botulinum Toxin Type-A in Cleft Lip Repair

Intervention

Drug:
• Botulinum toxin type A
Botulinum toxin type-A injection

Locations

Country	Name	City	State
Egypt	Cairo University	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Mostafa Khairy

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Scar Length		6 months